Analyst Research Report Snapshot

Title:

Glenmark Pharmaceuticals inches higher, resistance at 12-day EMA

Price:

$5.00

Provider:

BuySellSignals Research

Date:

10 Jul 2014

Pages:

19

Type:

AcrobatPDF

Companies referenced:

GLEN.NS

Available for Immediate Download
Summary:

Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK), India's 10th largest pharmaceuticals company by market cap, increased 0.2% but fell short of the 12-day Exponential Moving Average [EMA] of Rs575.32. Compared with the BSE Sensex Index which fell 72.1 points (or 0.3%) in the day, this represented a re...

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.